Hepatic Artery Transfusion of NKG2D CAR-NK Cells Followed by Intravenous Infusion of NKG2D CAR-T Cells to Treat Patients With Advanced Solid Tumors With Liver Metastases Who Have Failed Standard Treatments: a Phase I Exploratory Clinical Trial
PHASE1
This is a single-center, single-arm, open-label, dose-escalation clinical s...
Status
Recruiting
Location
The First Affiliated Hospital Zhejiang University School of Medicine
Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma
PHASE2
This phase II trial studies the side effects of cord blood-derived expanded...